Development and validation of a liquid chromatographic-tandem mass spectrometric method for determination of oseltamivir and its metabolite oseltamivir carboxylate in plasma, saliva and urine.

Development and validation of a liquid chromatographic-tandem mass spectrometric method for determination of oseltamivir and its metabolite oseltamivir carboxylate in plasma, saliva and urine.

A bioanalytical method for the analysis of oseltamivir (OP) and its metabolite oseltamivir carboxylate (OC) in human plasma, saliva and urine using off-line solid-phase extraction and liquid chromatography coupled to positive tandem mass spectroscopy has been developed and validated. OP and OC were...

書誌詳細
主要な著者:	Lindegårdh, N, Hanpithakpong, W, Wattanagoon, Y, Singhasivanon, P, White, N, Day, N
フォーマット:	Journal article
言語:	English
出版事項:	2007

類似資料

A liquid chromatographic-tandem mass spectrometric method for determination of artemether and its metabolite dihydroartemisinin in human plasma.
著者:: Hanpithakpong, W, 等
出版事項: (2009)

Population pharmacokinetics of oseltamivir and oseltamivir carboxylate in obese and Non-obese volunteers.
著者:: Chairat, K, 等
出版事項: (2016)

A liquid chromatographic-tandem mass spectrometric method for determination of artesunate and its metabolite dihydroartemisinin in human plasma.
著者:: Hanpithakpong, W, 等
出版事項: (2008)

Comparison of oseltamivir and oseltamivir carboxylate concentrations in venous plasma, venous blood, and capillary blood in healthy volunteers.
著者:: Instiaty, I, 等
出版事項: (2013)

Pharmacokinetics of high-dose oseltamivir in healthy volunteers.
著者:: Wattanagoon, Y, 等
出版事項: (2009)

Importance of collection tube during clinical studies of oseltamivir.
著者:: Lindegardh, N, 等
出版事項: (2007)

Rapid degradation of oseltamivir phosphate in clinical samples by plasma esterases.
著者:: Lindegardh, N, 等
出版事項: (2006)

Determination of Oseltamivir Quality by Colorimetric and Liquid Chromatographic Methods
著者:: Michael D. Green, 等
出版事項: (2008-04-01)

Validation and application of a liquid chromatographic-mass spectrometric method for determination of artesunate in pharmaceutical samples.
著者:: Lindegårdh, N, 等
出版事項: (2007)

Pharmacokinetics of orally administered oseltamivir in healthy obese and nonobese Thai subjects.
著者:: Jittamala, P, 等
出版事項: (2014)

Chemical analysis and transplacental transfer of oseltamivir and oseltamivir carboxylic acid in pregnant rats.
著者:: Chia-Chun Lin, 等
出版事項: (2012-01-01)

Pharmacokinetics of orally administered oseltamivir in healthy obese and nonobese thai subjects
著者:: Jittamala, P, 等
出版事項: (2014)

Plasma concentrations of oseltamivir and oseltamivir carboxylate in critically ill children on extracorporeal membrane oxygenation support.
著者:: Enno D Wildschut, 等
出版事項: (2010-01-01)

An open-label crossover study to evaluate potential pharmacokinetic interactions between oral oseltamivir and intravenous zanamivir in healthy Thai adults.
著者:: Pukrittayakamee, S, 等
出版事項: (2011)

An open-label crossover study to evaluate potential pharmacokinetic interactions between oral oseltamivir and intravenous zanamivir in healthy thai adults
著者:: Pukrittayakamee, S, 等
出版事項: (2011)

Development and validation of a liquid chromatographic-tandem mass spectrometric method for determination of piperaquine in plasma stable isotope labeled internal standard does not always compensate for matrix effects.
著者:: Lindegardh, N, 等
出版事項: (2008)

A physiologically-based pharmacokinetic model of oseltamivir phosphate and its carboxylate metabolite for rats and humans
著者:: Guanghua Gao, 等
出版事項: (2019-02-01)

Effects of dexamethasone coadministered with oseltamivir on the pharmacokinetics of oseltamivir in healthy volunteers
著者:: Jang K, 等
出版事項: (2017-03-01)

Ode to Oseltamivir and Amantadine?
著者:: JM Conly, 等
出版事項: (2006-01-01)

Combination therapy of nitazoxanide with oseltamivir compared with oseltamivir in hospitalized patients with seasonal influenza
著者:: Parvaiz A Koul, 等
出版事項: (2024-01-01)

Metabolism and disposition of oseltamivir (OS) in rats, determined by immunohistochemistry with monospecific antibody for OS or its active metabolite oseltamivir carboxylate (OC): A possibility of transporters dividing the drugs’ excretion into the bile and kidney
著者:: Kunio Fujiwara, 等
出版事項: (2020-06-01)

A simple and rapid liquid chromatographic assay for evaluation of potentially counterfeit Tamiflu.
著者:: Lindegårdh, N, 等
出版事項: (2006)

Impact of Oseltamivir and Diabetes Development
著者:: Bor-Show Tzang, 等
出版事項: (2025-01-01)

Impact of oseltamivir on the risk of cancer
著者:: Pei-Hua Chuang, 等
出版事項: (2024-02-01)

Rapid Emergence of Oseltamivir Resistance
著者:: Cheng Len Sy, 等
出版事項: (2010-04-01)

Assay to Detect Oseltamivir Resistance
著者:: Kamol Suwannakarn, 等
出版事項: (2006-12-01)

Oseltamivir in pregnancy and birth outcomes
著者:: Vera Ehrenstein, 等
出版事項: (2018-10-01)

Development and validation of a high-throughput zwitterionic hydrophilic interaction liquid chromatography solid-phase extraction-liquid chromatography-tandem mass spectrometry method for determination of the anti-influenza drug peramivir in plasma.
著者:: Lindegardh, N, 等
出版事項: (2008)

Liquid chromatographic-mass spectrometric method for simultaneous determination of small organic acids potentially contributing to acidosis in severe malaria.
著者:: Sriboonvorakul, N, 等
出版事項: (2013)

Development and validation of an automated solid phase extraction and liquid chromatographic method for the determination of piperaquine in urine.
著者:: Tarning, J, 等
出版事項: (2006)

Strategies for the Use of Oseltamivir and Zanamivir during Pandemic Outbreaks
著者:: Elsa Hansen, 等
出版事項: (2010-01-01)

OSELTAMIVIR MEDICATION IN THE PEDIATRIC PRACTICE: THE REVIEW
著者:: A.B. Ivanyuk, 等
出版事項: (2008-01-01)

OSELTAMIVIR MEDICATION IN THE PEDIATRIC PRACTICE: THE REVIEW
著者:: A.B. Ivanyuk, 等
出版事項: (2008-01-01)

Oseltamivir and G6PD deficiency
著者:: Şinasi Özsoylu
出版事項: (2010-06-01)

Oseltamivir and G6PD deficiency
著者:: Şinasi Özsoylu
出版事項: (2010-06-01)

Oseltamivir Enhances Hippocampal Network Synchronization
著者:: Atsushi Usami, 等
出版事項: (2008-01-01)

Oseltamivir for the treatment of influenza in children and adolescents
著者:: Alfredo Tagarro, 等
出版事項: (2019-05-01)

Wonderful drug for walking pneumonia: oseltamivir
著者:: Faheem Arshad, 等
出版事項: (2014-01-01)

Combination therapy with amantadine, oseltamivir and ribavirin for influenza A infection: safety and pharmacokinetics.
著者:: Seo, S, 等
出版事項: (2013)

Comparative effectiveness of combined favipiravir and oseltamivir therapy versus oseltamivir monotherapy in critically ill patients with influenza virus infection
著者:: Wang, Y, 等
出版事項: (2019)